𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

✍ Scribed by Richeldi, Luca; Costabel, Ulrich; Selman, Moises; Kim, Dong Soon; Hansell, David M.; Nicholson, Andrew G.; Brown, Kevin K.; Flaherty, Kevin R.; Noble, Paul W.; Raghu, Ganesh; Brun, Michèle; Gupta, Abhya; Juhel, Nolwenn; Klüglich, Matthias; du Bois, Roland M.

Book ID
120464189
Publisher
Massachusetts Medical Society
Year
2011
Tongue
English
Weight
864 KB
Volume
365
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Nintedanib in Idi
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
✍ Richeldi, Luca; du Bois, Roland M.; Raghu, Ganesh; Azuma, Arata; Brown, Kevin K. 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 565 KB

In patients with idiopathic pulmonary fibrosis, nintedanib reduced the decline in FVC, which is consistent with a slowing of disease progression; nintedanib was frequently associated with diarrhea, which led to discontinuation of the study medication in less than 5% of patients.